Keep What You Earn · 2026-08-04 · 20 min
Being booked feels like proof that the business is working. But if most of that schedule is filled with injectables, the revenue can look much stronger than the profit underneath it. Product costs, provider compensation, commissions, memberships, and discounting can leave very little behind - even when the calendar is full. In this solo episode, I break down why injectables need to be evaluated as part of your full service mix instead of carrying the entire growth strategy. I also explain how to organize your P&L by treatment category, calculate what patients actually contribute in gross profit, and use comprehensive treatment plans to improve both patient retention and practice profitability. A Full Injectable Schedule Can Still Produce Weak Profit Injectables are often one of the largest revenue categories in a medical aesthetics practice. They bring patients through the door, create recurring appointments, and can help establish long-term relationships. But with supply costs, injector compensation, commissions, and discounts factored in, gross margins may only land around 30% to 40%. That does not leave much room to cover the rest of the business.
Posting More Won't Fix Your Med Spa Marketing Strategy80 / 10010 Things to Fix Before Your Med Spa Wastes Any More Money on Ads50 / 100Reclaiming Your Role as a Medical Provider in a Retail-Minded Med Spa WorldCreating Autonomy: How to Make Your Med Spa Operate Without YouCombatting the Summer Slump: Mastering Inventory Management for Med Spa Cash Flow